A closer look at the technologies used by Dimension Therapeutics
Dimension Therapeutics
Business Services · 51-200 Employees
View Company Info for Free
Overview
Phone Number
(617) 401-0011Website
www.dimensiontx.comRevenue
$14.9 MillionIndustry
About Dimension Therapeutics
Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with rare and metabolic diseases associated with the liver. The company's pipeline of programs includes DTX101, a lead gene therapy product candidate designed to deliver FIX gene expression in patients with hemophilia B; and DTX201, a FVIII gene therapy program for the treatment of hemophilia A. Its pipeline programs also comprise DTX301, a gene therapy product candidate for the treatment of ornithine transcarbamylase deficiency; DTX401, a gene therapy program for the treatment of glycogen storage disease type Ia; DTX501, gene therapy program for the treatment of patients with PKU; DTX701, a gene therapy program for the treatment of Wilson disease; and DTX601, a gene therapy program for the treatment of citrullinemia type I. Dimension Therapeutics, Inc. was founded in 2013 and is based in Cambridge,...Explore more
SIC Code 87,873NAICS Code 54,541Show moreCompare Similar Companies to Dimension Therapeutics
Compare insights from companies similar to Dimension Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dimension Therapeutics
$14.9M
51-200
Private
-
2013
N/A
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
Dimension Therapeutics Tech Stack
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dimension Therapeutics
Sign Up For FreeTo access detailed company insights
Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with rare and metabolic diseases associated with the liver. The company's pipeline of programs includes DTX101, a lead gene therapy product candidate designed to deliver FIX gene expression in patients with hem... Read More